Herpes simplex virus 1 (HSV-1) ICP27 and ICP8 proteins have both been implicated in the transcription of late genes and regulation of viral gene expression. We showed previously that ICP27 and ICP8 associate with the RNAP II holoenzyme (Zhou and Knipe, J. Virol. 76,(5893)(5894)(5895)(5896)(5897)(5898)(5899)(5900)(5901)(5902)(5903)(5904). Here, we demonstrate that ICP27 and ICP8 coprecipitate from lysates of HSV-1-infected HEp2 cells and from lysates of insect cells expressing ICP27 and ICP8, the latter being in the absence of other HSV-1 proteins. By expressing and purifying hexahistidine-tagged ICP8 (His-ICP8) and maltose binding protein (MBP)-tagged ICP27 (MBP-27) proteins and performing in vitro immunoprecipitation and pull-down assays, we also demonstrate that ICP27 and ICP8 coprecipitate in the absence of other viral or cellular proteins. Taken together, these data provide evidence that ICP27 and ICP8 interact directly in vitro and in infected cells. We hypothesize that the ICP27-ICP8 interaction plays a role in the stimulation of late gene transcription. D
Introduction
The human herpes simplex virus 1 (HSV-1) has a linear, double-stranded DNA genome, encoding at least 80 genes that are transcribed in the cell nucleus by the host RNA polymerase II (RNAP II). The viral genes are expressed in a well-regulated, temporal fashion and can be divided into three broad classes: a or immediate-early (IE) genes, h or early (E) genes, and g or late (L) genes (reviewed in Roizman and Knipe, 2001 ). The L gene class can be further subdivided into g1 and g2 genes, the latter of which absolutely requires viral DNA replication for expression. Transcription of the five IE genes (ICP4, ICP0, ICP27, ICP22, and ICP47) is stimulated by the VP16 virion protein and does not require prior viral protein synthesis. Expression of the E proteins, which predominately include proteins essential for viral DNA synthesis, is regulated by IE proteins. Following the synthesis of E proteins and viral DNA replication, the L gene products are expressed, which consist mainly of viral structural proteins involved in virion assembly and maturation.
The expression of E and L proteins is dependent upon functional ICP4 and ICP27. ICP4 is a site-specific DNAbinding protein (Beard et al., 1986; Wilcox, 1986, 1988; Roizman, 1986a, 1986b; Michael et al., 1988; Purifoy and Powell, 1976 ) that interacts with basal transcription factors, including TFIID, TFIIB, TATA-binding protein (TBP), and TAF250 DeLuca, 1996, 1998; Grondin and DeLuca, 2000; Smith et al., 1993) , to activate the transcription of most early and late genes and repress the transcription of certain IE genes Godowski and Knipe, 1986; Kuddus et al., 1995; O'Hare and Hayward, 1985; Preston, 1979) . ICP27 is a nuclear IE phosphoprotein (Ackermann et al., 1984; Wilcox et al., 1980; Zhi and Sandri-Goldin, 1999 ) that is required for productive HSV-1 infection and is an essential regulator of viral gene expression (McCarthy et al., 1989; Rice and Knipe, 1990; Rice et al., 1989; Sacks et al., 1985) .
Studies with ICP27 gene null and deletion mutants have demonstrated that ICP27 stimulates the synthesis of several E proteins. As infection progresses, ICP27 represses the expression of certain IE and E proteins and induces the expression of g1 and g2 gene mRNAs and proteins, thereby promoting the switch from early to late gene expression. ICP27 also significantly enhances HSV-1 DNA synthesis, most likely by inducing the expression of E proteins essential for viral DNA replication (Uprichard and Knipe, 1996) . The effects of ICP27 on viral DNA replication and g2 gene expression are distinct. This is demonstrated by an ICP27 mutant (n504) virus that replicates viral DNA and expresses g1 proteins to near wild-type (wt) levels, but does not express g2 proteins (Jean et al., 2001; Rice and Knipe, 1990) . Studies with n504 virus-infected cells further show that ICP27 stimulates the transcription of at least two late genes, gC and U L 47 (Jean et al., 2001) . In support of a role for ICP27 as a transcriptional regulator, ICP27 has been shown to accumulate in replication compartments (de Bruyn Kops et al., 1998) , interact with the cellular RNAP II (Jenkins and Spencer, 2001; Zhou and Knipe, 2002) and with viral ICP0 and ICP4 proteins (Mullen et al., 1995; Panagiotidis et al., 1997) , and affect the posttranslational modification and DNA-binding activity of ICP4 (Samaniego et al., 1995; Xia et al., 1996) .
Other studies have also concluded that ICP27 functions at the posttranscriptional level. ICP27 binds to RNA in vitro and to many HSV-1 transcripts of all kinetic classes in vivo, primarily via the N-terminal RGG box RNA binding motif (Ingram et al., 1996; Mears and Rice, 1996; Sandri-Goldin, 1998; Sokolowski et al., 2003) . In infected or transfected cells, ICP27 regulates 3Vprocessing of pre-mRNAs (Ellison et al., 2000; Hann et al., 1998; McGregor et al., 1996; McLauchlan et al., 1992) , stabilizes labile 3Vends of mRNAs (Brown et al., 1995) , and contributes to host shut-off ) through inhibition of host cellular pre-mRNA splicing (Hardwicke and Sandri-Goldin, 1994a, 1994b; Lindberg and Kreivi, 2002) and retention of some introncontaining transcripts in the nucleus . In agreement with its posttranscriptional functions, ICP27 was reported to interact with a variety of cellular proteins, including p32 (Bryant et al., 2000) , SAP145 (Bryant et al., 2001) , SRPK1 (Sciabica et al., 2003) , Aly/REF (Chen et al., 2002) , hnRNP K, and CK2 (Wadd et al., 1999) . Later in infection, low levels of ICP27 shuttle between the cell nucleus and the cytoplasm, and ICP27 has been reported to promote the nuclear export of late viral mRNAs (reviewed in Sandri-Goldin, 2004) ; however, recent data have shown that the ICP27-mediated cytoplasmic accumulation of mRNAs is restricted to a limited number of transcripts (Pearson et al., 2004) .
ICP8 is one of seven early viral proteins essential for viral genome replication (Challberg, 1986; Conley et al., 1981) ; reviewed in Lehman and Boehmer, 1999 ) that binds tightly and cooperatively to ssDNA (Lee and Knipe, 1985; Ruyechan, 1983 Ruyechan, , 1988 , destabilizes dsDNA helices (Boehmer and Lehman, 1993) , promotes DNA strand transfer (Bortner et al., 1993) , and promotes renaturation of ssDNA (Dutch and Lehman, 1993) . ICP8 also regulates viral gene expression by repressing transcription from the parental viral genome (Godowski and Knipe, 1983 , 1986 and stimulating L gene expression from the progeny genome (Gao and Knipe, 1991) . ICP8 has recently been shown to associate in replication compartments with over 50 cellular and viral proteins-many of which are involved in DNA replication and repair, recombination, and chromatin modeling (Taylor and Knipe, 2004) . ICP8 also associates with ICP4, ICP27, and cellular RNAP II; however, the association of ICP8 with RNAP II is dependent on the expression of a functional ICP27 (Zhou and Knipe, 2002) .
Given that ICP27 is required for ICP8 to associate with RNAP II and that ICP27 and ICP8 are essential positive regulators of late gene expression, we hypothesized a direct interaction between ICP27 and ICP8. In the present study, we show that ICP27 and ICP8 specifically associate in HSV-1-infected cells. In addition, ICP27 and ICP8 associate in insect cells in the absence of other viral proteins. Finally, we provide evidence using purified, tagged proteins that ICP27 and ICP8 interact directly. We propose that the ICP27-ICP8 interaction plays a crucial role in stimulating the transcription of viral L genes.
Results

ICP27 and ICP8 specifically associate in HSV-1-infected cells
Previous studies from our lab have suggested an interaction between HSV-1 ICP27 and ICP8. We have shown that ICP27 and ICP8 associate with the cellular RNAP II holoenzyme in HSV-1-infected HEp-2 cells (Zhou and Knipe, 2002) . In addition, the association of ICP8 with RNAP II required functional ICP27. We also observed that ICP8 co-immunoprecipitated with ICP27 using anti-ICP27 H1119 mAb (Zhou and Knipe, 2002) and ICP27 coimmunoprecipitated with ICP8 using anti-ICP8 39S mAb (Taylor and Knipe, 2004) , suggesting an interaction between ICP27 and ICP8. In this study, we sought to further investigate a potential interaction between the two proteins.
In the first set of experiments, we tested the association between ICP27 and ICP8 in HSV-1-infected cells. HEp-2 cells were mock infected or infected with wt virus or d27-1 virus, an ICP27 null deletion mutant. Cells were harvested at 8 hpi, and immunoprecipitations were performed on the cellular lysates with antibodies either to ICP27 (H1119 mAb) or ICP8 (3-83 pAb). In ICP27 immunoprecipitations, ICP8 co-immunoprecipitated from wt virus-infected cellular lysates (Fig. 1A, lane 6) . Conversely, ICP27 co-immunoprecipitated with ICP8 from wt virus-infected cellular lysates (Fig. 1B, lane 6 ). Little to no ICP27 or ICP8 precipitated with the beads alone, that is, without primary antibody (Fig. 1B,  lane 7) . Furthermore, ICP8 did not precipitate with H1119 mAb in the absence of ICP27, that is, from cell lysates infected with d27-1 virus (Fig. 1A , lane 5), demonstrating that the co-immunoprecipitation of ICP27 and ICP8 was specific. Previous immunoprecipitation studies from infected cell lysates used a monoclonal antibody to ICP8 (39S) (Taylor and Knipe, 2004) . Here, we used an antibody other than 39S that also recognizes ICP8 (3-83) to further demonstrate an association between ICP27 and ICP8. Therefore, these results showed a specific association between ICP27 and ICP8 during HSV-1 infection.
Characterization of ICP27 and His-tagged ICP8 proteins
We next determined if other HSV-1 proteins were necessary for the association between ICP27 and ICP8. To address this, we tested if ICP27 and His-tagged ICP8 (His-ICP8) expressed by recombinant baculoviruses in insect cells could co-immunoprecipitate in the absence of other HSV-1 proteins. Before beginning the immunoprecipitation experiments, it was necessary to ensure that the ICP27 and ICP8 constructs we used produced stable, functional proteins. We first tested the ICP27 gene construct with a complementation assay performed in mammalian cells. The ICP27 open reading frame (ORF) was inserted into the pCIDAflII mammalian expression vector and tested for its ability to complement the ICP27 null deletion virus d27-1. The pCI-ICP27 plasmid complemented the growth of the d27-1 virus to a titer 10 4 -fold higher than that in cells transfected with the pCIDAflII vector (Table 1 ). In addition, this level of complementation was similar to that of the positive control pPs27pd1, which expressed full-length ICP27 under the control of the endogenous viral promoter. Thus, the subcloned ICP27 gene translated into a functional protein in mammalian cells. Because insect cells are functionally similar to mammalian cells in that both cell types incorporate posttranslational modifications, splice genes, and compartmentalize proteins (King and Possee, 1992; Luckow, 1991) , these data suggested the insect baculovirus vector would express a functional ICP27 protein.
Several investigators have generated and expressed Histagged ICP8 that is similar to our recombinant protein to high levels in insect cells. These investigators have provided evidence that ICP8 expressed by baculovirus recombinant binds cooperatively to short DNA poly (dT) oligonucleotides and to ssDNA agarose (Dudas and Ruyechan, 1998; Mapelli et al., 2000; Spatz et al., 1999) . In addition, these properties of ICP8 are not disrupted by the presence of a hexahistidine tag (Spatz et al., 1999 ). Nevertheless, we tested whether our His-ICP8-retained ssDNA-binding activity to the same levels reported for wt ICP8. Cellular lysate from SF21 cells infected with the recombinant ICP8 baculovirus was passed over an ssDNA agarose column and His-ICP8 was eluted with buffer containing increasing amounts of salt. His-ICP8 had an elution profile similar to wt ICP8 (data not shown; Gao and Knipe, 1989; Lee and Knipe, 1985) , suggesting that the protein was functional and had similar DNA binding properties compared with wt. Therefore, we concluded that Fig. 1 . Co-precipitation of ICP27 and ICP8 from HSV-1-infected cells. HEp-2 cells were infected with wt or ICP27 deletion mutant (d27-1) viruses or mock infected, and the cells were harvested at 8 hpi. Immunoprecipitations (IP) were performed on cell lysates with (A) a-ICP27 H1119 mAb, (B) a-ICP8 3-83 pAb, or no antibody (beads). Proteins in the lysate (1% of the total precleared lysate used in immunoprecipitations was loaded on the gel) and in the IP were resolved by SDS-PAGE and detected by Western blotting (WB) with H1119 (1:300 dilution) or 3-83 (1:1000 dilution) as primary antibodies. MW; molecular weight of the protein standards. 10,000 a Vero cells were transfected with 1.5 Ag of pCI-ICP27, pCI-MBP-ICP27, pCI alone (mock; negative control), or pPs27pd1 (positive control) plasmids. Cells were infected with d27-1 virus and harvested at 24 hpi. b Virus yields were determined in duplicate on V827 cells. c Fold complementation of d27-1 virus by transfected plasmid above mock-transfected.
His-ICP8 and ICP27 expressed by recombinant baculoviruses were functional.
ICP27 and His-ICP8 co-immunoprecipitated in the absence of other HSV-1 proteins
To address whether ICP27 and ICP8 associate without other HSV-1 proteins, SF21 insect cells were mock infected, infected with baculoviruses expressing ICP27 or His-ICP8, or co-infected with ICP27 and His-ICP8 baculoviruses. Cells were harvested at 72 hpi, and immunoprecipitations were performed on cellular lysates with either anti-ICP27 H1119 mAb or anti-ICP8 3-83 pAb. The co-immunoprecipitated proteins were separated by SDS-PAGE and detected by Western blot analysis with either H1119 or 3-83 as primary antibodies.
His-ICP8 co-immunoprecipitated with ICP27 from cellular lysates expressing both ICP27 and His-ICP8 recombinant proteins in immunoprecipitations performed with H1119 ( Fig The failure of ICP8 to precipitate with the anti-ICP27 antibody without the expression of ICP27, and vice versa, indicated that ICP27 and ICP8 specifically associated when expressed in insect cells and that other HSV proteins were not necessary for the ICP27-ICP8 association.
Characterization and co-precipitation of tagged ICP27 (MBP-27) and ICP8 (His-ICP8)
We further determined if purified ICP27 and ICP8 proteins could interact directly in vitro. To determine this, we expressed affinity-tagged ICP27 and ICP8 constructs to ease purification. For these experiments, we made use of His-ICP8 expressed by the recombinant ICP8 baculovirus described above, which we expressed to high levels in TnHi5 insect cells and purified to near homogeneity via a three-column protocol (Fig. 3B, lane 4) .
Unfortunately, many investigators have had little success expressing full-length ICP27 with an N-terminal affinity tag to high levels (Mears and Rice, 1996; Sciabica et al., 2003; Jean and Knipe, unpublished data) . We made several unsuccessful attempts to express ICP27 with N-terminal hexahistidine or GST affinity tags in insect cells. His-tagged ICP27 was expressed to negligible levels in insect cells, and the GST-tagged ICP27 protein was insoluble (results not shown). Because expression as a maltose binding protein (MBP) fusion protein has increased the solubility of several proteins expressed in bacteria (Planson et al., 2003) , we generated a construct, termed MBP-27, in which ICP27 was fused to the C-terminus of Escherichia coli MBP. MBP-27 was expressed in E. coli and partially purified on amylose resin, which binds with high affinity and specificity to E. coli MBP. Similar to other reports for ICP27 proteins expressed in bacteria, we observed prominent bands that were likely to be degraded or truncated MBP-27 products, but were able to obtain soluble full-length MBP-27 (Fig. 3A, lane 2) . Previous reports have shown that H1119 mAb does not recognize Nterminally tagged ICP27 proteins, likely because the tag masks the antibody recognition site. H1119 did not detect MBP-27 in Western blots, but we confirmed the identity of MBP-27 by Western blotting with an antibody to MBP and by mass spectrometry (results not shown).
To test the functionality of the MBP-27 protein, we cloned the ORF encoding MBP-27 into the pCIDAflII expression vector (pCI-MBP27) and performed a complementation assay to determine if pCI-MBP27 could complement the growth of the ICP27 null deletion virus d27-1 in mammalian cells. The pCI-MBP27 plasmid complemented d27-1 viral growth by 100-fold greater than mock (pCIDAflII)-transfected cells, but 40-fold less than wt pCI-ICP27 (Table 1) . Thus, the gene encoding MBP-27 translated into a protein that retained most wt functions. We are not certain why MBP-27 did not complement d27-1 as well as wt ICP27, but possible explanations include interference by the MBP tag, differing levels of ICP27 and MBP-27 protein expression, or altered structure of MBP-27 compared with wt ICP27 in Vero cells.
To determine if MBP-27 could co-immunoprecipitate with His-ICP8 in vitro, these tagged proteins were expressed and purified as described in Materials and methods and were incubated separately or together in IP buffer overnight. Immunoprecipitations were then performed on these samples with the anti-ICP8 3-83 pAb. MBP-27 co-immunoprecipitated with His-ICP8 (Fig. 4A, lane 4) . We occasionally observed a low level of background when MBP-27 was incubated with 3-83 pAb alone (Fig. 4A, lane 2) ; however, the Western blot signal for MBP-27 when both proteins were incubated together was consistently higher, demonstrating specificity for the interaction. In addition, neither MBP-27 nor His-ICP8 was precipitated when incubated together with a bead control in the absence of antibody (data not shown). Interestingly, even though our partially purified MBP-27 preparation contained two highly expressed MBP-27 degradation or truncation products (Fig. 3, lane 2; and Fig. 4A , lane 1), these products did not co-precipitate with ICP8 (Fig. 4A, lane 4) . The blot was subsequently stripped and probed with 3-83 pAb by Western blotting to detect His-ICP8 in the immunoprecipitated samples (Fig. 4B, lanes 1  and 3-4) . The results of these experiments provide evidence for a direct interaction between ICP27 and ICP8.
The reverse immunoprecipitations were not feasible because available antibodies did not recognize MBP-27 in immunoprecipitation assays. Therefore, we used protein affinity pull-down assays as an alternative approach to determine whether ICP27 and ICP8 interact directly. MBP or the MBP-27 fusion was expressed in E. coli and bound to amylose resin. The conjugated beads were washed extensively to remove the loosely bound E. coli proteins and incubated with purified His-ICP8. The beads were washed and boiled in protein loading buffer, and bound proteins were detected by SDS-PAGE and Western blot. His-ICP8 bound to MBP-27 (Fig. 5A, lane 4) , but not to MBP or to resin alone (Fig. 5A, lanes 3 and 2,  respectively) . Moreover, reovirus A2 protein that was expressed in and purified from insect cells did not bind MBP-27 or MBP in pull-down experiments (FontaineRodriguez et al., in press) . These negative controls demonstrate additional specificity for the interaction of His-ICP8 with MBP-27. The blot was stripped and probed with an antibody against MBP to show that MBP and MBP-27 were bound to amylose resin (Fig. 5B) . These results provide evidence for a direct interaction between ICP27 and ICP8.
Previous studies, which showed that ICP27 and ICP8 associated in HSV-1-infected HEp-2 cells in the presence of RNase or ethidium bromide (EtBr), suggested that RNA or DNA did not mediate the ICP27-ICP8 association (Taylor and Knipe, 2004; Zhou and Knipe, 2002) . The conditions of our purification schemes for His-ICP8, which included the presence of DNase and levels of salt high enough to disrupt protein-nucleic acid interactions, as well as the ability of His-ICP8 to bind an ssDNA column suggested that neither DNA nor RNA was present in the purified preparation we used for in vitro assays. However, we considered that nucleic acids could be present in our partially purified MBP-27 preparations. Therefore, to confirm that the interaction between ICP27 and ICP8 was direct, we performed a pulldown assay in which bacterial lysates containing MBP and MBP-27 were treated with RNase and DNase prior to binding to amylose resin. His-ICP8 co-precipitated with MBP-27 with or without nuclease treatment (Fig. 6 , lanes 4 and 5), but did not co-precipitate with MBP in either condition (Fig. 6, lanes 2 and 3) . Taken together, these results and those of the aforementioned studies with virus-infected cells (Taylor and Knipe, 2004; Zhou and Knipe, 2002) argue strongly that the ICP27-ICP8 interaction is direct and mediated primarily by protein-protein interactions.
Discussion
ICP27 and ICP8 interact directly
Previous studies from our laboratory suggested a direct interaction between ICP27 and ICP8. Both ICP27 and ICP8 associated with RNAP II in lysates of HSV-1-infected cells (Jenkins and Spencer, 2001; Zhou and Knipe, 2002) .
Furthermore, the association of ICP8 with RNAP II required the presence of a functional ICP27 (Zhou and Knipe, 2002) . ICP27 was also shown to co-precipitate with ICP8 from replication compartments of HSV-1-infected cells (Taylor and Knipe, 2004) . In this study, we have extended past work and present novel evidence that ICP27 and ICP8 interact directly and specifically, and in the absence of other HSV-1 or cellular proteins.
Previous studies have shown that the association of ICP27 and ICP8 in HSV-1-infected HEp-2 cells is not disrupted in the presence of RNAse or ethidium bromide (EtBr), suggesting that RNA or DNA did not mediate their association (Taylor and Knipe, 2004; Zhou and Knipe, 2002) . To exclude the possibility that RNA or DNA was mediating the ICP27-ICP8 interaction, we performed pulldown assays in the presence of RNase and DNase and observed a direct interaction of purified His-tagged ICP8 with MBP-27. We therefore concluded that the interaction between ICP27 and ICP8 was mediated predominantly by protein-protein interactions.
Although we have shown evidence for a bona fide ICP27-ICP8 interaction, we cannot exclude the possibility that the interaction could be strengthened via associations with other viral or cellular proteins during HSV-1 infection. Support for assistance from other proteins extends from the ability of ICP27 to interact with RNAP II and ICP4 (see below).
ICP27 and ICP8 mutants share defects in late gene expression
Studies with the n504 ICP27 and d105 ICP8 mutants support the idea of a direct ICP27-ICP8 interaction. The n504 ICP27 nonsense mutant virus, which encodes the Nterminal 504 amino acid residues of ICP27, is defective for L gene (g2) expression, but replicates near wt levels of DNA (Jean et al., 2001; Rice and Knipe, 1990) . The d105 ICP8 mutant is a dominant-negative form of ICP8 that lacks residues 1083-1166 (Chen and Knipe, 1996; Gao and Knipe, 1991) . Cells expressing d105 ICP8 and infected with wt HSV-1 exhibited markedly reduced mRNA and protein levels of g1 (ICP5, ICP25) and g2 (ICP15, gC, U L 47) genes compared with wt virus-infected cells. Furthermore, the effects on L gene transcription were independent of viral DNA synthesis (Chen and Knipe, 1996) . Given that mutations in these two genes impart similar functional consequences, these data suggest that ICP27 and ICP8 collaborate in the mechanism by which L genes are expressed. Moreover, these data are consistent with a direct interaction between ICP27 and ICP8 during viral infection. Because results with the n504 ICP27 virus show that amino acid residues in the C-terminus of ICP27 are necessary for at least the expression of g2 late genes, we are currently exploring the requirement of specific amino acid residues within the C-terminus for the ICP27-ICP8 interaction.
Implications of the ICP27 and ICP8 interaction in viral gene expression
Both ICP27 and ICP8 have been implicated in the stimulation of transcription of several true L genes. The mechanism by which ICP27 and ICP8 stimulate L gene transcription has not been defined previously, but ICP27 was shown to associate and co-localize with RNAP II, ICP8, and ICP4 in replication compartments (de Bruyn Kops et al., 1998; Taylor and Knipe, 2004; Zhou and Knipe, 2002) , which are sites where viral DNA replication and viral gene transcription are thought to occur. Moreover, ICP27 showed a direct interaction with ICP4 (Mullen et al., 1995; Panagiotidis et al., 1997) , which is a site-specific DNA binding protein (Beard et al., 1986; Wilcox, 1986, 1988; Roizman, 1986a, 1986b; Michael et al., 1988; Purifoy and Powell, 1976 ) that associates with general transcription factors DeLuca, 1996, 1998; Grondin and DeLuca, 2000; Smith et al., 1993) presumably to promote transcription of viral mRNA. We show here that ICP27 also interacts with ICP8, an ssDNA binding protein that stimulates L gene expression, like ICP27, specifically from the progeny viral genome (Gao and Knipe, 1991) . We therefore propose that the interaction of ICP27 and ICP8, and their associations with other viral and cellular proteins (i.e., RNAP II and ICP4), play a role in stimulating transcription of at least viral L genes. Our heuristic model predicts that ICP27 binds to RNAP II (Zhou and Knipe, 2002) , and this complex is recruited to viral DNA via interactions of ICP27 with ICP8 and ICP4 (Fig. 7) . These interactions may serve to bring RNAP II to progeny viral DNA, thereby promoting the efficient transcription of viral L genes.
Our data provide evidence for a genuine and potentially functionally relevant ICP27-ICP8 interaction. The interaction between ICP27 and ICP8 may serve to stimulate at least the expression, if not transcription, of certain viral genes. Currently, we are investigating the regions of ICP27 responsible for interactions with ICP8 and vice versa. Efforts to determine the three-dimensional structure of ICP8 (Mapelli and Tucker, 1999) , ICP27, and the complex of the two proteins should help to further elucidate the mechanisms by which HSV-1 commandeers the host cell nucleus.
Materials and methods
Materials
The H1119 ICP27-specific mouse monoclonal antibody (mAb) (Ackermann et al., 1984) was purchased from the Goodwin Institute for Cancer Research Inc. (Plantation, FL). The 3-83 ICP8-specific rabbit polyclonal antibody (pAb) was described previously (Knipe et al., 1987) . Anti-MBP mAb was purchased from New England Biolabs (Beverly, MA).
Cell culture
African green monkey kidney (Vero), human 293, and human epidermoid (HEp2) cells were obtained from the American Type Culture Collection (Manassas, VA) and maintained in Dulbecco's modified Eagle's medium (Media Tech Inc., Herndon, VA) supplemented with 5% fetal bovine serum (FBS) (Invitrogen, Carlsbad, CA) plus 5% fetal calf serum (FCS) (Hyclone, Logan, UT), streptomycin (100 Ag/ml), and penicillin (100 U/ml) (DMEM + 10% FBCS). V827 cells (Da Costa et al., 2000) , which contain an integrated copy of the ICP27 and ICP8 genes, were also grown in DMEM + 10% FBCS. SF21 cells were grown in Grace's insect media plus 10% FBS and streptomycin (100 Ag/ml) and penicillin (100 U/ml) at 27 8C (Invitrogen). TnHi5 cells were maintained in spinner cultures in Express Five SFM supplemented with 18 mM l-glutamine, and streptomycin (100 Ag/ml) and penicillin (100 U/ml) at 27 8C (Invitrogen).
Plasmids, baculoviruses, and HSV-1 strains
The pPs27pd1 plasmid was described previously (Rice et al., 1989) . To construct the pCI-ICP27 plasmid, which expresses ICP27 in mammalian cells, the ICP27 open reading frame (ORF) was first amplified from pPs27pd1 with the Advantage GC-2 PCR kit (BD Biosciences, San Jose, CA). The 5V -primer (ICP27-Eco RI-5V ; 5V -CGGAATTCGTCATGGCGACTGACATTGA-3V ) was complementary to nucleotides 1-17 (underlined) and had at its 5Vend an EcoRI restriction enzyme site (bold). The 3V primer (ICP27-XbaI-3V ; 5V -GCTCTAGAGTACCTAAAA-CAGGGAGTTGC-3V ) was complementary to bases 1519-1536 and contained an XbaI restriction site (bold) at its 5V end. The 1.5 kb PCR amplification product was subcloned into the EcoRI and XbaI sites of the pCI (Promega)-derived vector pCIDAflII (Murphy et al., 2000) . The subcloned ICP27 ORF was verified by sequencing.
The pMal-Dest-ICP27-inducible bacterial expression plasmid, which expresses ICP27 as a maltose binding protein (MBP) fusion, was constructed as follows. The pMal-Dest vector, a gift from Brent Appleton and Jim Hogle (Harvard Medical School, MA), was engineered from pMAL-c2X (New England Biolabs) to contain sequence encoding a PreScission protease site (Amersham Biosciences, Piscataway, NJ), Gateway recombination sites (Invitrogen), and EcoRI and XbaI restriction sites 3V to the malE ORF. The ICP27 ORF from pCI-ICP27 was subcloned into the engineered EcoRI and XbaI sites of pMal-Dest vector, in frame with malE, to yield pMal-Dest-ICP27. The pCI-MBP27 plasmid, which expresses the MBP-ICP27 fusion protein in mammalian cells, was generated by digestion of pMal-Dest-ICP27 with NdeI and XbaI restriction enzymes. The NdeI and XbaI sites were blunt ended by Klenow Polymerase (New England Biolabs) and the DNA fragment was subcloned into the SmaI site of the pCIDAflII vector. The orientation of the inserted DNA fragment in pCIDAflII was determined via analysis with restriction enzymes.
The pFastbac-ICP27 plasmid was created by subcloning the ICP27 ORF from pCI-ICP27 into the EcoRI and XbaI sites of pFastbac vector (Invitrogen). To construct the pFastbacHT29 plasmid, the ICP8 ORF (UL29) was subcloned in two steps from the CMV-8.3 plasmid (Taylor et al., 2003) into pFastbacHT (Invitrogen), which contains sequence encoding a hexahistidine affinity tag in the 5V direction from the subcloned gene. First, an EcoRI and SalI fragment, containing approximately 3350 nucleotides of UL29, was subcloned from SV8.3 into pFastbacHT in frame with the His-tag to generate pFastbacHTdsb. Second, a small SalI fragment from SV8.3, containing the 3V end of UL29, was subcloned into pFastbacHTdsb to construct the full-length UL29 construct (pFastbacHT29). Baculoviruses for ICP27 and His-ICP8 were generated from pFastbac-ICP27 and pFastbacHT29 in SF21 cells with the Invitrogen Fastbac system.
HSV-1 KOS 1.1 (wt) strain (Hughes and Munyon, 1975 ) was propagated on Vero cells. The previously described ICP27 null deletion mutant virus d27-1 (Rice and Knipe, 1990) was grown on V827 cells.
Complementation assay
Vero cells were grown in T-25 flasks to 90% confluence. Cells in duplicate flasks were transfected with 1.5 Ag of pCI-ICP27, pCI-MBP27, or pPs27pd1 plasmids or pCIDAflII empty vector (mock control). Transfections were performed with Lipofectamine 2000 reagent (Invitrogen). Cells were washed four times with cold phosphate-buffered saline (PBS) 24 h post-transfection and subsequently infected with d27-1, the ICP27 null deletion mutant virus, at an MOI of 5 PFU/cell at 37 8C. After 1 h, the cells were washed four times with PBS to remove unabsorbed virus, and 5 ml of DMEM + 1% FBCS was added to the infected flask. Cells were harvested at 24 hpi by freeze-thawing and sonicating three times for 30 s on ice. Complementation of virus growth was measured by plaque assay on the V827 ICP27-complementing cell line.
Purification of His-ICP8 from TnHi5 insect cells
TnHi5 cells were grown in 1-l spinner flasks to a density of 6 Â 10 5 to 1 Â 10 6 cells/ml before infection with the recombinant ICP8 baculovirus. After incubation at 27 8C for 72-96 h, the infected cells were collected by centrifugation at 500 Â g for 15 min. The cell pellets were washed twice with PBS and suspended in lysis buffer (50 mM Tris-Cl, pH 7.7, 150 mM NaCl, 15% glycerol, 10 mM 2-mercaptoethanol (h-ME), 5 mM EDTA, 0.2% NP40, 200 AM PMSF, and one Complete protease inhibitor cocktail tablet [Roche Applied Science, Indianapolis, IN] per 20 ml). Cells were incubated on ice for 30 min and disrupted by Dounce homogenization. The cell lysate was clarified by centrifugation (15,000 Â g; 20 min; 4 8C) and applied to a Sepharose Q FF anion exchange column (Amersham Biosciences) equilibrated with Buffer A (20 mM Tris-Cl, pH 7.7, 150 mM NaCl, 15% glycerol, 10 mM h-ME). His-ICP8 was eluted from the resin with a linear salt gradient (0.15-0.5 M NaCl) in Buffer A and fractions containing His-ICP8 were identified by UV absorbance and SDS-PAGE, collected, and dialyzed against several changes of Buffer B (50 mM Tris-Cl, pH 7.7, 150 mM NaCl, 5 mM EDTA, 15% glycerol, and 10 mM h-ME). The dialyzed sample was applied to an ssDNA agarose column (Amersham Biosciences), equilibrated with Buffer B. His-ICP8 was eluted from the resin with Buffer B plus 1 M NaCl. The fractions containing His-ICP8 were pooled, dialyzed against Buffer C (20 mM Tris-Cl, pH 7.7, 500 mM NaCl, 20% glycerol, and 4 mM h-ME), and applied to a nickel affinity column (Amersham Biosciences) equilibrated with Buffer C. His-ICP8 was eluted from the nickel affinity resin with a linear gradient of imidazole (0.05-0.5 M) in Buffer C. His-ICP8 fractions were pooled, dialyzed against Buffer D (20 mM Tris, pH 7.7, 300 mM NaCl, 20% glycerol, 4 mM TCEP (Amersham Biosciences), and stored at À80 8C in aliquots. Protein concentration was determined by absorbance at 280 nm (Pace et al., 1995) and by Coomassie staining relative to a bovine serum albumin standard curve resolved by SDS-PAGE.
Purification of MBP-27 from BL21 E. coli cells ICP27 was expressed in E. coli as a fusion protein at the carboxy terminus of MBP. BL21-codon-optimized competent E. coli cells (Stratagene, La Jolla, CA) were transformed with pMal-Dest-ICP27, and transformants were selected on LB agar plates containing 100 Ag/ml carbenicillin (SigmaAldrich, St. Louis, MO). Three-liter cultures of transformed cells were grown in 2YT, 100 Ag/ml carbenicillin, and 11 mM glucose at 37 8C with shaking until the optical density at 600 nm was approximately 0.6. IPTG was added to a final concentration of 0.5 mM, and cells were incubated at 16 8C overnight. The cells were harvested by low-speed centrifugation for 20 min, washed once with cold MBP buffer (20 mM Tris-HCl, 200 mM NaCl, 8 mM h-ME, 1 mM EDTA, 20% glycerol, 1 Complete protease inhibitor cocktail tablet [Roche Applied Science] per 20 ml), and lysed by sonication in MBP buffer containing DNase. All subsequent steps were performed at 4 8C. Supernatants were collected by centrifugation at 15,000 Â g and applied to 2 ml column containing amylose resin (New England Biolabs) that was equilibrated with MBP buffer. The resin was washed with 5 column volumes of MBP buffer and MBP-27 was eluted with MBP buffer plus 10 mM maltose. Protein concentration was determined via Coomassie staining relative to a bovine serum albumin standard curve resolved by SDS-PAGE.
Immunoprecipitation assays
To prepare cellular lysates from mammalian cells for immunoprecipitation assays, we mock infected or infected HEp2 cells with HSV-1 KOS 1.1 (wt) or d27-1 viruses at an MOI of 20 PFU/cell and harvested the infected cells at 8 hpi. Cells were lysed on ice in 0.5-1 ml IP buffer (20 mM Trisacetate, pH 7.9, 40 mM NaCl, 1 mM EDTA, 120 mM potassium-acetate, 1 mM DTT, 0.005-0.1% Nonidet P-40, 10% glycerol, and one Complete protease inhibitor cocktail tablet [Roche Applied Science] per 20 ml) for 30 min. Cellular lysates were clarified by centrifugation in an Eppendorf microfuge for 10 min at 16,000 Â g. For insect cell immunoprecipitation assays, SF21 cells were mock infected or infected with recombinant ICP27 or ICP8 baculoviruses and harvested and lysed at 72 hpi as above. To perform immunoprecipitation assays on purified proteins, MBP-27 and His-ICP8 that were purified as described were diluted separately or in combination in 0.5 ml IP buffer and incubated overnight at 4 8C with gentle rotation.
All subsequent steps were performed at 4 8C. The cell lysates and purified protein samples were precleared with an equal mix of Protein A-and Protein G-coated beads (Roche Applied Science) for 1 h to overnight. Five microliters of H1119 mAb or 1-3 Al of 3-83 pAb was added to the samples for 1 h with gentle rotation. Beads (25-50 Al) were added and samples were incubated for an additional hour. The beads were washed four times with IP buffer and boiled in protein loading buffer prior to resolution of the immunoprecipitates by SDS-PAGE and Western blotting.
Protein affinity pull-down assays BL21 codon-optimized E. coli cells were transformed with pMAL-Dest-ICP27 or pMAL-c2X plasmids, and recombinant MBP-27 and MBP proteins were expressed in E. coli as described above. Bacterial cells from 1-L cultures were harvested via low speed centrifugation and lysed in 20 ml MBP buffer by sonication. Approximately 40 Al of amylose resin was washed with MBP buffer and subsequently blocked with MBP buffer + 2% BSA for 45 min at 4 8C. The blocked resin was washed with MBP buffer and incubated with 500 Al MBP-27 or 50 Al MBP supernatants for 2 h at 4 8C. Less MBP lysate was used because MBP was expressed at levels approximately 10-fold higher than MBP-27. MBP fusion-conjugated beads were washed five times with MBP buffer, twice with IP buffer (above), and incubated with 2.5 Ag of purified ICP8 in IP buffer overnight. Blocked, unconjugated resin was used as a negative control for ICP8 nonspecific binding. After four washes at 10 min each with IP buffer, SDS-PAGE sample buffer was added and the beads were boiled for 10 min. Samples were analyzed via SDS-PAGE and Western blotting, and His-ICP8 was detected with 3-83 pAb. Subsequently, the membrane was stripped and probed with the anti-MBP mAb to detect MBP and MBP-27. RNase (Ambion, Austin, TX; 25 U of RNase A/ml and 1000 U of RNase T 1 /ml) and DNase (Sigma-Aldrich; 50 Ag/ml) incubations were performed with cleared bacterial lysates at 30 8C for 30 min prior to binding to amylose resin.
SDS-PAGE and Western blotting
Proteins were resolved on either 8-16% gradient or 10% Tris-Glycine precast gels (Invitrogen) or diallytartardiamide cross-linked 9.25% polyacrylamide gels. Gels were stained with Coomassie Brilliant Blue R-250 (American Bioanalytical, Natick, MA) or transferred to polyvinyldene difluoride (PVDF) membranes (Perkin-Elmer Life Sciences, Inc., Boston, MA) at 40 V overnight in transfer buffer (25 mM Tris, 192 mM glycine, 15% methanol, pH 8.3). The membranes were blocked in 5% milk in Tris-buffered saline containing 0.05% Tween 20 (TBS-T) (pH 8.0) and probed with the indicated primary antibodies. The anti-ICP27 (H1119), anti-ICP8 (3-83), and anti-MBP antibodies were used at 1:300, 1:1000, and 1:10,000 dilutions, respectively. Goat anti-rabbit and goat anti-mouse secondary antibodies were diluted 1:10,000 in TBS-T. The proteins were visualized with ECL Western blotting detection reagents (Amersham Biosciences) according to the manufacturerV s protocol. The membranes were stripped in 100 mM h-ME, 2% sodium dodecyl sulfate, 62.5 mM Tris-HCl, pH 6.7 at 56 8C for 1 h before reprobing.
